迪哲医药-U
(688192)
| 流通市值：52.32亿 | | | 总市值：176.69亿 |
| 流通股本：1.23亿 | | | 总股本：4.16亿 |
| 报告期 | 2024-03-31 | 2023-12-31 | 2023-09-30 | 2023-06-30 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 流动资产: | | | | |
| 货币资金 | 95,312,852.54 | 74,201,573.96 | 69,398,112.49 | 81,416,420.46 |
| 应收票据及应收账款 | 44,131,815 | 48,040,333.77 | 45,802,064 | - |
| 应收账款 | 44,131,815 | 48,040,333.77 | 45,802,064 | - |
| 预付款项 | 49,810,954.8 | 53,142,591.08 | 81,047,477.15 | 71,409,968.54 |
| 其他应收款合计 | 3,404,754.13 | 3,370,300.9 | 3,725,764.98 | 4,212,325.65 |
| 其中:应收利息 | - | - | 357,868.77 | 266,048.02 |
| 存货 | 33,444,320.21 | 23,470,661.27 | 20,086,101.78 | 13,266,274.39 |
| 其他流动资产 | 31,226,876.97 | 34,137,629.49 | 20,975,461.28 | 16,395,056.84 |
| 流动资产平衡项目 | 0 | 0 | 0 | 0 |
| 流动资产合计 | 978,932,665.1 | 910,361,387.23 | 1,084,851,232.36 | 1,135,420,457.12 |
| 非流动资产: | | | | |
| 固定资产 | 22,654,904.05 | 22,095,817.03 | 19,906,451.53 | 21,348,528.49 |
| 在建工程 | 17,846,629.35 | 13,347,166.35 | 11,466,811.4 | 15,249,513.29 |
| 使用权资产 | 60,666,515.12 | 66,813,996.86 | 73,411,847.99 | 78,584,863.56 |
| 无形资产 | 454,185,792.1 | 461,979,190.5 | 469,536,632.21 | 475,536,753.88 |
| 长期待摊费用 | 15,099,564.54 | 16,986,644.25 | 10,776,786.15 | 8,081,593.67 |
| 其他非流动资产 | 2,852,188.73 | 4,794,365.22 | 3,393,162.36 | 5,011,455.96 |
| 非流动资产平衡项目 | 0 | 0 | 0 | 0 |
| 非流动资产合计 | 573,305,593.89 | 586,017,180.21 | 588,491,691.64 | 603,812,708.85 |
| 资产平衡项目 | 0 | 0 | 0 | 0 |
| 资产总计 | 1,552,238,258.99 | 1,496,378,567.44 | 1,673,342,924 | 1,739,233,165.97 |
| 流动负债: | | | | |
| 短期借款 | 264,550,678.88 | 200,114,966.97 | 199,920,121.95 | 79,648,344.08 |
| 应付票据及应付账款 | 159,544,478.09 | 108,932,147.81 | 194,969,072.22 | 149,172,349.2 |
| 应付账款 | 159,544,478.09 | 108,932,147.81 | 194,969,072.22 | 149,172,349.2 |
| 合同负债 | 1,541,600 | 981,760 | - | - |
| 应付职工薪酬 | 36,701,975.35 | 55,957,058.75 | 62,925,710.34 | 40,578,657.49 |
| 应交税费 | 11,483,017.77 | 12,435,727.5 | 4,928,037.89 | 4,080,445.92 |
| 其他应付款合计 | 51,831,626.66 | 46,965,759.15 | 39,850,121.49 | 22,209,671.13 |
| 其中:应付利息 | - | - | 186,928.86 | - |
| 一年内到期的非流动负债 | 19,056,441.86 | 23,048,164.79 | 24,209,035.53 | 23,093,813.89 |
| 流动负债平衡项目 | 0 | 0 | 0 | 0 |
| 流动负债合计 | 544,709,818.61 | 448,435,584.97 | 526,802,099.42 | 318,783,281.71 |
| 非流动负债: | | | | |
| 长期借款 | 256,873,746.11 | 138,313,291.49 | - | - |
| 租赁负债 | 42,667,813.68 | 48,894,490.52 | 49,837,357.19 | 59,309,705.05 |
| 递延收益 | 11,394,214.22 | 12,107,784.66 | 14,429,882 | 14,567,979.35 |
| 非流动负债平衡项目 | 0 | 0 | 0 | 0 |
| 非流动负债合计 | 310,935,774.01 | 199,315,566.67 | 64,267,239.19 | 73,877,684.4 |
| 负债平衡项目 | 0 | 0 | 0 | 0 |
| 负债合计 | 855,645,592.62 | 647,751,151.64 | 591,069,338.61 | 392,660,966.11 |
| 所有者权益(或股东权益): | | | | |
| 实收资本(或股本) | 415,653,120 | 408,151,370 | 408,151,370 | 408,151,370 |
| 资本公积 | 3,018,739,304.21 | 2,954,040,912.77 | 2,908,923,420.31 | 2,858,525,045.08 |
| 未分配利润 | -2,737,799,757.84 | -2,513,564,866.97 | -2,234,801,204.92 | -1,920,104,215.22 |
| 归属于母公司股东权益平衡项目 | 0 | 0 | 0 | 0 |
| 归属于母公司股东权益合计 | 696,592,666.37 | 848,627,415.8 | 1,082,273,585.39 | 1,346,572,199.86 |
| 股东权益平衡项目 | 0 | 0 | 0 | 0 |
| 股东权益合计 | 696,592,666.37 | 848,627,415.8 | 1,082,273,585.39 | 1,346,572,199.86 |
| 负债和股东权益合计 | 1,552,238,258.99 | 1,496,378,567.44 | 1,673,342,924 | 1,739,233,165.97 |
| 公告日期 | 2024-04-30 | 2024-04-30 | 2023-10-28 | 2023-08-30 |
| 审计意见(境内) | | 标准无保留意见 | | |